Whistleblower Protections for FDA and Private-Sector Employees

Overview:

This paper discusses the whistleblower protection laws that impact both the FDA and publicly traded pharmaceutical companies. The author outlines how and why the Sarbanes-Oxley act applies to drug manufacturers, analyzes the Act’s statutory language, and explores the procedures by which one would bring a Sarbanes-Oxley whistleblower claim.